Published in
Taylor and Francis Group, Emerging Microbes and Infections, 1(10), p. 874-884, 2021
DOI: 10.1080/22221751.2021.1921621
Links
Tools
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
Journal article published in 2021 by
Bao-Zhong Zhang,
Xiaolei Wang,
Shuofeng Yuan 
,
Wenjun Li,
Ying Dou,
Vincent Kwok-Man Poon ,
Chris Chung-Sing Chan,
Jian-Piao Cai,
Kenn KaHeng Chik,
Kaiming Tang,
Chris Chun-Yiu Chan,
Ye-Fan Hu,
Jing-Chu Hu,
Smaranda Ruxandra Badea,
Hua-Rui Gong
and other authors.
,
Wenjun Li,
Ying Dou,
Vincent Kwok-Man Poon ,
Chris Chung-Sing Chan,
Jian-Piao Cai,
Kenn KaHeng Chik,
Kaiming Tang,
Chris Chun-Yiu Chan,
Ye-Fan Hu,
Jing-Chu Hu,
Smaranda Ruxandra Badea,
Hua-Rui Gong
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 